Guardant Health (GH) director adds 4,203 shares and receives 2,711 RSUs

Rhea-AI Filing Summary

Guardant Health director Tariq Musa reported routine equity compensation activity. On June 17, 2026, he exercised 4,203 Restricted Stock Units into the same number of common shares following full vesting tied to the 2026 Annual Meeting of Stockholders.

He also received a new grant of 2,711 Restricted Stock Units that will vest in full on the one-year anniversary of the grant date, June 17, 2026, or on the date of Guardant Health’s next annual meeting of stockholders, whichever is earlier. Following these transactions, Musa directly holds 12,999 shares of common stock and 2,711 Restricted Stock Units, with no shares sold.

Insights

Equity compensation analyst

Routine RSU vesting and grant, no open-market trading.

Guardant Health, Inc. director Tariq Musa reported equity movements entirely from stock-based compensation on June 17, 2026. He exercised 4,203 Restricted Stock Units into common shares after they vested in full at the 2026 Annual Meeting of Stockholders.

On the same date, he received a new award of 2,711 Restricted Stock Units that will vest on the earlier of the one-year anniversary of the grant date or the next annual meeting. No open‑market purchases or sales occurred, and the filing shows 12,999 common shares held directly plus 2,711 RSUs outstanding.

Insider Trade Summary

4,203 shares exercised/converted

Mixed 3 txns

Insider Tariq Musa

Role null

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,203	$0.00	--
Grant/Award	Restricted Stock Units	2,711	$0.00	--
Exercise	Common Stock	4,203	$0.00	--

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct, null); Common Stock — 12,999 shares (Direct, null)

Footnotes (1)

1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026. Not applicable for Restricted Stock Units. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.

Key Figures

RSUs exercised: 4,203 shares New RSU grant: 2,711 units Common shares held after transactions: 12,999 shares +3 more

6 metrics

RSUs exercised 4,203 shares Restricted Stock Units converted to common stock on June 17, 2026

New RSU grant 2,711 units Restricted Stock Units granted on June 17, 2026

Common shares held after transactions 12,999 shares Direct ownership following June 17, 2026 transactions

RSUs outstanding after grant 2,711 units Restricted Stock Units scheduled to vest in full after grant conditions

Exercise transactions 1 exercise, 4,203 shares Derivative exercise/conversion count and size in transaction summary

Acquire-type transactions 3 transactions Total acquire-direction entries (exercise and grant) in transaction summary

Key Terms

Restricted Stock Units, derivative security, Annual Meeting of Stockholders, grant, award, or other acquisition

4 terms

Restricted Stock Units financial

"The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

Annual Meeting of Stockholders financial

"the 2026 Annual Meeting of Stockholders which was held on June 17, 2026"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/22/2026 - 05:55 PM Accepted by SEC EDGAR 06/22/2026 - 05:55 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tariq Musa

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		M		4,203	A	$0	12,999	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	06/17/2026		M			4,203	(1)	(2)	Common Stock	4,203	$0	0	D
Restricted Stock Units	$0	06/17/2026		A		2,711		(3)	(2)	Common Stock	2,711	$0	2,711	D

Explanation of Responses:

1. The restricted stock unit award vested in full on the date of the 2026 Annual Meeting of Stockholders which was held on June 17, 2026.

2. Not applicable for Restricted Stock Units.

3. The restricted stock unit award vests in full on the one-year anniversary of the grant date, June 17, 2026, or the date of the Company's next annual meeting of stockholders, whichever is earlier.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Musa Tariq	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did Guardant Health (GH) director Tariq Musa report?

Tariq Musa reported exercising 4,203 Restricted Stock Units into common stock and receiving a new grant of 2,711 Restricted Stock Units on June 17, 2026. All movements were equity compensation-related, with no shares sold in the market.

How many Guardant Health shares does Tariq Musa hold after this Form 4?

After the reported transactions, Tariq Musa directly holds 12,999 shares of Guardant Health common stock. In addition, he has 2,711 Restricted Stock Units outstanding, which are scheduled to vest in full based on the next annual meeting or one-year anniversary condition.

What equity awards did Tariq Musa receive from Guardant Health on June 17, 2026?

On June 17, 2026, Tariq Musa received a grant of 2,711 Restricted Stock Units. According to the terms, this award will vest in full on June 17, 2027 or on the date of Guardant Health’s next annual stockholder meeting, whichever occurs earlier.

Did Tariq Musa buy or sell Guardant Health (GH) shares on the open market?

The Form 4 does not show any open-market purchases or sales by Tariq Musa. All reported activity involves exercising 4,203 previously granted Restricted Stock Units into common stock and receiving a new 2,711-unit Restricted Stock Unit grant as compensation.

How did the 2026 Annual Meeting affect Tariq Musa’s Guardant Health RSUs?

A prior Restricted Stock Unit award vested in full on the date of Guardant Health’s 2026 Annual Meeting of Stockholders, held on June 17, 2026. That full vesting triggered the exercise of 4,203 Restricted Stock Units into 4,203 common shares reported in the filing.